Hall et al. suggested that inhibition of P53 and activation of MYC signaling pathways in normal astrocytes exposed to GBM-EVs might be a mechanism by which glioblastoma(GBM) manipulates astrocytes to acquire a phenotype that promotes tumor progression (Hallal et al., 2019). Here, TP53 is linked to glioblastoma.